Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METOPROLOL Cause Peripheral t-cell lymphoma unspecified recurrent? 5 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Peripheral t-cell lymphoma unspecified recurrent have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.0% of all adverse event reports for METOPROLOL.

5
Reports of Peripheral t-cell lymphoma unspecified recurrent with METOPROLOL
0.0%
of all METOPROLOL reports
0
Deaths
3
Hospitalizations

How Dangerous Is Peripheral t-cell lymphoma unspecified recurrent From METOPROLOL?

Of the 5 reports, 3 (60.0%) required hospitalization.

Is Peripheral t-cell lymphoma unspecified recurrent Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does METOPROLOL Cause?

Drug ineffective (3,434) Dyspnoea (3,428) Dizziness (3,275) Hypotension (3,213) Completed suicide (2,959) Fatigue (2,784) Off label use (2,580) Toxicity to various agents (2,404) Bradycardia (2,024) Nausea (1,894)

What Other Drugs Cause Peripheral t-cell lymphoma unspecified recurrent?

BELINOSTAT (15) PRALATREXATE (11) PREDNISONE (9) BRENTUXIMAB VEDOTIN (8) CYCLOPHOSPHAMIDE (8) DOXORUBICIN (8) ETOPOSIDE (7) RUXOLITINIB (7) MIRTAZAPINE (5) PANTOPRAZOLE (5)

Which METOPROLOL Alternatives Have Lower Peripheral t-cell lymphoma unspecified recurrent Risk?

METOPROLOL vs METRELEPTIN METOPROLOL vs METRONIDAZOLE METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE METOPROLOL vs METYRAPONE METOPROLOL vs MEXILETINE

Related Pages

METOPROLOL Full Profile All Peripheral t-cell lymphoma unspecified recurrent Reports All Drugs Causing Peripheral t-cell lymphoma unspecified recurrent METOPROLOL Demographics